Does Alpha-Lipoic Acid Blood Pressure Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Alpha-Lipoic Acid Blood Pressure Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - A random-effects meta-analysis using the REML estimator was applied to calculate relative risk (RR), including continuity corrections for zero-event studies. [Pena E (2026); evidence level 1] - Data extraction was performed in duplicate, and risk of bias was evaluated using the Cochrane tool. [Pena E (2026); evidence level 1] - Pooled estimates showed a non-significant trend toward reduced AMS incidence with antioxidant treatment (RR ≈ 0.73; 95% CI: 0.47-1.11; p = 0.14). [Pena E (2026); evidence level 1] - Acute Mountain Sickness (AMS) is a frequent condition triggered by exposure to hypobaric hypoxia at high altitude. [Pena E (2026); evidence level 1] - Experimental data and clinical studies highlight the cardiometabolic changes associated with gonadal aging and reproductive hormones’ withdrawal []. [Karaflou Maria (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.